Enzolytics, Inc. Receives Official Filing Receipt for Multiple Sclerosis Patent Application
Enzolytics, Inc. Receives Official Filing Receipt for Multiple Sclerosis Patent Application Third Tranche of $1.2 Million Financing Completed COLLEGE STATION, TX / ACCESSWIRE / January 19, 2021 / Enzolytics, Inc. (OTC PINK:ENZC)(the "Company") today, announced it has received the official filing receipt from the U.S. Patent Office confirming the filing of its patent application for "Nuclear Proteins Isolated from Mammalian Spinal Cord Immune Factor - Pharmaceutical Composition for Treatment" and has received the third tranche of the $1.2 million dollar financing. The Company expects to file t...
Source: finanznachrichten.de